Sid­dhartha Mukher­jee’s cell ther­a­py start­up nar­rows fo­cus as staff shrinks

Myeloid Ther­a­peu­tics, a com­pa­ny de­vel­op­ing in vi­vo cell ther­a­pies for can­cer as well as a nov­el gene edit­ing tech­nol­o­gy, has re­struc­tured to fo­cus on its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER